SMIM8: A Protein of Interest as A Drug Target Or Biomarker (G57150)

Target Name: SMIM8

NCBI ID: G57150

SMIM8

SMIM8: A Protein of Interest as A Drug Target Or Biomarker

SMIM8, also known as DJ102H19.2, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of immediate-early gene (SEG) proteins, which are known for their ability to induce rapid gene expression in response to various stimuli.

SMIM8 has been shown to play a role in a variety of physiological processes in the body, including cell signaling, neurotransmission, and inflammation. Its function is still not well understood, but its potential as a drug target or biomarker is being investigated.

One of the main reasons for the interest in SMIM8 is its potential as a drug target. SMIM8 has been shown to interact with a variety of molecules, including ion channels, neurotransmitters, and signaling proteins. Its interaction with these molecules suggests that it may be a useful target for small molecules that can modulate its function.

SMIM8 has also been shown to play a role in neurotransmission. In addition to its interaction with ion channels, SMIM8 has been shown to interact with neurotransmitters such as dopamine, serotonin, and GABA. These interactions suggest that SMIM8 may be involved in the regulation of neurotransmitter signaling, which is important for a variety of physiological processes, including mood, pain, and movement.

SMIM8's role in inflammation is also being investigated. Its expression has been shown in a variety of tissues that are involved in inflammation, including the brain, spleen, and lymphoid organs. Additionally, studies have shown that SMIM8 can modulate the production of pro-inflammatory cytokines, which may contribute to inflammation.

In addition to its potential as a drug target or biomarker, SMIM8 is also of interest as a potential biomarker for certain diseases. Its expression has been shown in a variety of tissues that are involved in disease, including the brain, heart, and kidneys. This suggests that it may be a useful biomarker for a variety of diseases, including neurodegenerative disorders, cardiovascular disease, and renal disease.

SMIM8 is also of interest as a potential therapeutic target for a variety of diseases. Its interaction with ion channels, neurotransmitters, and signaling proteins suggests that it may be a useful target for small molecules that can modulate its function. Additionally, its role in cell signaling and neurotransmission suggest that it may be a useful target for drugs that target signaling pathways involved in disease.

In conclusion, SMIM8 is a protein that is of interest as a drug target or biomarker. Its interaction with ion channels, neurotransmitters, and signaling suggests proteins that it may be a useful target for small molecules that can modulate its function. Further studies are needed to fully understand its role in physiological processes and its potential as a drug target or biomarker.

Protein Name: Small Integral Membrane Protein 8

The "SMIM8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SMIM8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets